The Current Ratio as of September 2024 (TTM) for Cipher Pharmaceuticals Inc. (CPHRF) is 11.18

According to Cipher Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 11.18. This represents a change of 38.05% compared to the average of 8.10 of the last 4 quarters.

Cipher Pharmaceuticals Inc. (CPHRF) Historical Current Ratio (quarterly & annually)

How has CPHRF Current Ratio performed in the past?

The mean historical Current Ratio of Cipher Pharmaceuticals Inc. over the last ten years is 2.76. The current 11.18 Current Ratio has changed 40.40% with respect to the historical average. Over the past ten years (40 quarters), CPHRF's Current Ratio was at its highest in in the June 2024 quarter at 11.18. The Current Ratio was at its lowest in in the September 2019 quarter at 0.95.

Cipher Pharmaceuticals Inc. (CPHRF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Cipher Pharmaceuticals Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cipher Pharmaceuticals Inc. (CPHRF) Average Current Ratio

How has CPHRF Current Ratio performed in the past?

The current Current Ratio of Cipher Pharmaceuticals Inc. (CPHRF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cipher Pharmaceuticals Inc. (CPHRF) Current Ratio vs. Peers

How is CPHRF’s Current Ratio compared to its peers?

Cipher Pharmaceuticals Inc.’s Current Ratio is greater than Bionoid Pharma Inc. (0.34), greater than CENTR Brands Corp. (0.08), greater than CTT Pharmaceutical Holdings, Inc. (0), greater than Alterola Biotech, Inc. (0.08), greater than Crescita Therapeutics Inc. (3.37), greater than Cannara Biotech Inc. (2.32), greater than Knight Therapeutics Inc. (3.41), greater than Lowell Farms Inc. (1.14), greater than Aion Therapeutic Inc. (0.18), greater than HLS Therapeutics Inc. (2.02), greater than Canntab Therapeutics Limited (0.57),

Build a custom stock screener for Cipher Pharmaceuticals Inc. (CPHRF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cipher Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cipher Pharmaceuticals Inc. (CPHRF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cipher Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.